MedTrace Logo

MMS, IFA, and MMS+IFA Supplementation in Pregnant Women

NCT07665957 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 402

Last updated 2026-07-01

No results posted yet for this study

Summary

This study aims to compare the effectiveness of Multiple Micronutrient Supplementation (MMS), Iron-Folic Acid (IFA) supplementation, and combined MMS+IFA supplementation among pregnant women. Maternal anemia and micronutrient deficiencies are common during pregnancy and can adversely affect both maternal and neonatal health outcomes.

A total of 402 pregnant women with gestational age of 20 weeks or less will be randomly assigned to receive MMS, IFA, or combined MMS+IFA supplementation. Participants will be followed throughout pregnancy until delivery. Maternal hemoglobin levels, maternal compliance with supplementation, and neonatal outcomes including birth weight, preterm birth, APGAR scores, and congenital anomalies will be assessed.

The findings of this study will provide evidence to guide antenatal nutrition policies and practices in Pakistan.

Conditions

  • Maternal Anemia
  • Micronutrient Deficiency
  • Pregnancy Outcomes
  • Maternal Nutrition

Interventions

DIETARY_SUPPLEMENT

Multiple Micronutrient Supplementation (MMS)

WHO-standard multiple micronutrient supplement containing iron, folic acid, zinc, iodine, vitamins A, D, C, and B-complex vitamins administered daily during pregnancy

DIETARY_SUPPLEMENT

Iron-Folic Acid (IFA)

Iron 60 mg and folic acid 400 µg administered daily during pregnancy.

Sponsors & Collaborators

  • Sindh Institute of Child Health and Neonatology

    lead OTHER

Principal Investigators

  • Rozina Feroz Ali, MBBS, MSC · Sindh Institute of Child Health and Neonatology

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-06-25
Primary Completion
2026-12-25
Completion
2027-01-25

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07665957 on ClinicalTrials.gov